Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway

Abstract Background Resistance can develop during treatment of advanced endometrial cancer (EC), leading to unsatisfactory results. Fanconi anemia complementation group D2 (Fancd2) has been shown to be closely related to drug resistance in cancer cells. Therefore, this study was designed to explore...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Hai-Hong Lin, Wei-Hong Zeng, Hai-Kun Yang, Li-Shan Huang, Ru Pan, Nan-Xiang Lei
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2024-01-01
Sarja:	BMC Women's Health
Aiheet:	Fancd2 Endometrial cancer Chemotherapeutic agents Drug resistance Ferroptosis
Linkit:	https://doi.org/10.1186/s12905-023-02857-4
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!